Support this! 620 cases of death entered into FDA Adverse Events Reporting System
Mitragynine related adverse events totaled 1096 which includes 620 cases of death. Its unregulated status allows easy access and misuse. Schedule I classification is necessary to protect public health and reduce overdose incidents.
